Ron Wyden sold Solventum Corp. (NYSE: SOLV)
Ron Wyden (D-OR), a U.S. Senator, has disclosed 1 trade in Solventum Corp. (SOLV) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Ron Wyden sold $1,001 - $15,000 of Solventum Corp. (NYSE: SOLV) on February 6, 2025. Since that trade, SOLV is up +2.01% against the S&P 500 up +25.80%, an outperformance of -23.79%.
Data updated
Ron Wyden's SOLV trades vs the price
SOLV is up +2.01% since Ron Wyden sold on February 6, 2025, versus +25.80% for the S&P 500.
Performance since this trade
All Ron Wyden SOLV trades
Ron Wyden & SOLV trading FAQ
Is it legal for Ron Wyden to trade Solventum Corp. (SOLV) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Solventum Corp. (SOLV), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Ron Wyden sell SOLV?
Ron Wyden disclosed a sale of $1,001 - $15,000 of Solventum Corp. (SOLV) on February 6, 2025, according to public STOCK Act filings.
How has SOLV performed since Ron Wyden's trade?
Since Ron Wyden sold SOLV on February 6, 2025, the stock is up +2.01%, versus +25.80% for the S&P 500 over the same period, an outperformance of -23.79%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional SOLV trades?
Quantellect tracks every disclosed congressional trade in Solventum Corp. (SOLV) on the Solventum Corp. congressional trading page, which aggregates filings across all members of Congress.
Ron Wyden's SOLV tradesAll congressional filings for Solventum Corp.Ron Wyden's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.